Cargando…
Current Status of Immunomodulatory and Cellular Therapies in Preclinical and Clinical Islet Transplantation
Clinical islet transplantation is a β-cell replacement strategy that represents a possible definitive intervention for patients with type 1 diabetes, offering substantial benefits in terms of lowering daily insulin requirements and reducing incidences of debilitating hypoglycemic episodes and unawar...
Autores principales: | Chhabra, Preeti, Brayman, Kenneth L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199196/ https://www.ncbi.nlm.nih.gov/pubmed/22046502 http://dx.doi.org/10.1155/2011/637692 |
Ejemplares similares
-
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation
por: Jahansouz, Cyrus, et al.
Publicado: (2011) -
Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations
por: Tatum, Jacob A, et al.
Publicado: (2017) -
Current Status of Pancreas and Islet Cell Transplantation
por: Saidi, R. F.
Publicado: (2012) -
The Current Status of Allogenic Islet Cell Transplantation
por: Czarnecka, Zofia, et al.
Publicado: (2023) -
Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation
por: Huurman, Volkert A. L., et al.
Publicado: (2008)